Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China
· Delayed Price · Currency is CNY 72.97
-0.49 (-0.67%)
At close: Dec 5, 2025
SHE:300573 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 17,982 | 12,229 | 22,715 | 11,076 | 11,263 | 7,612 | Upgrade
|
| Market Cap Growth | 9.41% | -46.16% | 105.08% | -1.66% | 47.96% | 29.71% | Upgrade
|
| Enterprise Value | 17,736 | 11,973 | 22,352 | 10,579 | 11,226 | 7,679 | Upgrade
|
| Last Close Price | 72.97 | 48.70 | 89.40 | 43.39 | 47.03 | 32.62 | Upgrade
|
| PE Ratio | 27.78 | 36.17 | 94.63 | 52.33 | 57.85 | 86.52 | Upgrade
|
| PS Ratio | 7.47 | 6.29 | 15.48 | 8.86 | 10.96 | 11.05 | Upgrade
|
| PB Ratio | 9.68 | 7.68 | 13.44 | 7.14 | 8.38 | 10.97 | Upgrade
|
| P/TBV Ratio | 10.51 | 8.38 | 14.09 | 7.27 | 8.52 | 11.56 | Upgrade
|
| P/FCF Ratio | 43.92 | 56.03 | 408.51 | - | 53.15 | 543.47 | Upgrade
|
| P/OCF Ratio | 28.28 | 29.33 | 71.53 | 38.69 | 36.69 | 62.32 | Upgrade
|
| EV/Sales Ratio | 7.37 | 6.16 | 15.23 | 8.46 | 10.92 | 11.15 | Upgrade
|
| EV/EBITDA Ratio | 20.24 | 23.95 | 65.68 | 35.59 | 37.73 | 48.73 | Upgrade
|
| EV/EBIT Ratio | 23.08 | 29.32 | 85.99 | 45.76 | 46.72 | 68.51 | Upgrade
|
| EV/FCF Ratio | 43.32 | 54.85 | 401.97 | - | 52.98 | 548.27 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.14 | 0.05 | 0.01 | 0.08 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 0.15 | 0.42 | 0.23 | 0.05 | 0.36 | 0.51 | Upgrade
|
| Debt / FCF Ratio | 0.33 | 0.99 | 1.42 | - | 0.53 | 5.71 | Upgrade
|
| Asset Turnover | 1.05 | 0.94 | 0.77 | 0.72 | 0.78 | 0.76 | Upgrade
|
| Inventory Turnover | 2.96 | 2.93 | 2.64 | 2.52 | 2.85 | 2.54 | Upgrade
|
| Quick Ratio | 1.51 | 1.41 | 2.83 | 4.69 | 3.23 | 0.94 | Upgrade
|
| Current Ratio | 1.90 | 1.80 | 3.48 | 5.68 | 3.69 | 1.39 | Upgrade
|
| Return on Equity (ROE) | 37.08% | 20.59% | 14.81% | 14.62% | 20.52% | 14.73% | Upgrade
|
| Return on Assets (ROA) | 20.85% | 12.30% | 8.54% | 8.33% | 11.33% | 7.71% | Upgrade
|
| Return on Capital (ROIC) | 24.84% | 14.27% | 9.74% | 9.56% | 13.47% | 9.74% | Upgrade
|
| Return on Capital Employed (ROCE) | 40.00% | 24.50% | 14.70% | 14.20% | 16.90% | 14.90% | Upgrade
|
| Earnings Yield | 3.59% | 2.76% | 1.06% | 1.91% | 1.73% | 1.16% | Upgrade
|
| FCF Yield | 2.28% | 1.79% | 0.24% | -0.12% | 1.88% | 0.18% | Upgrade
|
| Dividend Yield | 1.10% | 2.20% | 2.11% | 1.26% | 0.50% | 0.28% | Upgrade
|
| Payout Ratio | 64.73% | 138.01% | 74.36% | 38.19% | 24.21% | 18.41% | Upgrade
|
| Buyback Yield / Dilution | -0.66% | -0.70% | -0.96% | -7.45% | 0.30% | -2.88% | Upgrade
|
| Total Shareholder Return | 0.80% | 1.50% | 1.15% | -6.19% | 0.80% | -2.60% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.